ANRO Stock Analysis: Buy, Sell, or Hold?
ANRO - Alto Neuroscience Inc.
$16.16
0.35 (2.21%)
▲
5d:
-3.87%
30d:
-2.59%
90d:
+13.88%
BUY
HIGH Confidence
Last Updated: February 3, 2026
Earnings: Mar 19, 2026
Smart Money Accumulation
ANRO is down 3.7% this week, but smart money is accumulating calls. Top strike: $20 2026-04-17 with 55 OI. Call ratio: 100% View Scanner →
Strength: 6.8/10
Get Alerted When ANRO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ANRO shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: ANRO shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: ANRO is currently trading at $16.16, which is considered slightly low relative to its 30-day fair value range of $15.76 to $17.49.
Technical Outlook: Technically, ANRO is in a strong uptrend. Immediate support is located at $14.38, while resistance sits at $18.09.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $31.12 (+92.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ANRO is in a strong uptrend. Immediate support is located at $14.38, while resistance sits at $18.09.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $31.12 (+92.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$15.76 -
$17.49
Company Quality Score
54/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 92.6% below Wall St target ($31.12)
Fair Price Analysis
30-Day Fair Range
$15.76 -
$17.49
Current vs Fair Value
SLIGHTLY LOW
Expected Move (7 Days)
±$2.85
(17.6%)
Support & Resistance Levels
Support Level
$14.38
Resistance Level
$18.09
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-7.59
Wall Street Target
$31.13
(+92.6%)
Last updated: February 04, 2026 5:51 AM ET
Data refreshes hourly during market hours. Next update: 6:51 AM
Data refreshes hourly during market hours. Next update: 6:51 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ANRO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 56 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1036 | 58 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 65 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 53 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
